XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.21.1

Earnings Per Share | 3 Months Ended
--- | ---
Mar. 31, 2021
Earnings Per Share [Abstract] |
EARNINGS PER SHARE | EARNINGS PER SHARE The following table sets forth the computation of basic and diluted earnings per share for the three months ended March 31, 2021 and 2020 (in thousands, except per share amounts):
| Three Months Ended March 31, |  |
| 2021 |  | 2020 |  |  |  |
Earnings per Common Share - basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Net income | $ | 29,311 |  |  | $ | 175,309 |  |  |  |  |
Net income attributable to noncontrolling interests in CPLP from continuing operations | (6) |  |  | (302) |  |  |  |  |
Net income attributable to other noncontrolling interests | (195) |  |  | (64) |  |  |  |  |
Net income available to common stockholders | $ | 29,110 |  |  | $ | 174,943 |  |  |  |  |
Denominator: |  |  |  |  |  |  |
Weighted average common shares - basic | 148,624 |  |  | 147,424 |  |  |  |  |
Net income per common share - basic | $ | 0.20 |  |  | $ | 1.19 |  |  |  |  |
Earnings per common share - diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Net income | $ | 29,311 |  |  | $ | 175,309 |  |  |  |  |
Net income attributable to other noncontrolling interests | (195) |  |  | (64) |  |  |  |  |
Net income available for common stockholders before allocation of net income attributable to noncontrolling interests in CPLP | $ | 29,116 |  |  | $ | 175,245 |  |  |  |  |
Denominator: |  |  |  |  |  |  |
Weighted average common shares - basic | 148,624 |  |  | 147,424 |  |  |  |  |
Add: |  |  |  |  |  |  |
Potential dilutive common shares - stock options | 4 |  |  | 15 |  |  |  |  |
Potential dilutive common shares - restricted stock units, less shares assumed purchased at market price | 72 |  |  | 2 |  |  |  |  |
Weighted average units of CPLP convertible into common shares | 25 |  |  | 1,120 |  |  |  |  |
Weighted average common shares - diluted | 148,725 |  |  | 148,561 |  |  |  |  |
Net income per common share - diluted | $ | 0.20 |  |  | $ | 1.18 |  |  |  |  |
Anti-dilutive stock options represent stock options whose exercise price exceeds the average market value of the Company’s stock. As of March 31, 2021 and December 31, 2020, there were no anti-dilutive stock options included in the calculation of dilutive weighted average shares. As of March 31, 2021, the Company has no stock options outstanding.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration